ABL signs international joint venture



    Clifton Mining Company Inc. (OTC : CFTN)

    ALPINE, UT, Feb. 8 /CNW/ - American Biotech Labs (ABL), a private company
(Clifton Mining Company owns 22% of ABL) announces that they have just signed
a joint venture with International Minerals and Metals, Inc. (IMM), to develop
markets in 59 countries.

    The New Venture
    ---------------
    IMM is a private international company that has built a longstanding
network of joint ventures in 59 countries, under the direction of its chairman
Mr. Philip M. Lynch. This joint venture network will become the basis for the
next round of sales growth for ABL as well as for humanitarian aid purposes.
Over the last year, the management of ABL has personally met with many of
these joint venture partners in Dubai, Singapore, China, India, and Europe,
etc., in preparation for the new ABL/IMM joint venture.

    Management Comment
    ------------------
    The management of ABL feels that this joint venture will open doors in
numerous countries world wide, where the SilverSol Technology(TM) products are
needed, to promote health and wellness.
    Clifton trades on the U.S. OTC: (CFTN).

    Note: Any statements released by Clifton Mining Company that are forward
    looking are made pursuant to the safe harbor provisions of the Private
    Securities Litigation Reform Act of 1995. Editors and investors are
    cautioned that forward looking statements invoke risk and uncertainties
    that may affect the company's business prospects and performance.





For further information:

For further information: Dr. Ken Friedman, President at (303) 642-0659;
Keith Moeller, Vice President at (801) 756-1414; or see our website at
www.cliftonmining.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890